CST3 and neoplasm: We have further demonstrated that increased levels of cystatin C in pretreated patients were decreased once those patients attained remission after treatment with chemotherapy, proposing that cystatin C levels are allied to tumor burden and could be valued and useful in monitoring the disease response.